Standard InChI: InChI=1S/C15H13NO3/c17-13-8-6-11(10-14(13)18)7-9-15(19)16-12-4-2-1-3-5-12/h1-10,17-18H,(H,16,19)/b9-7+
Standard InChI Key: WWYUUQYLTXYLBK-VQHVLOKHSA-N
Associated Targets(Human)
HCT-116 91556 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
A-431 6446 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein-tyrosine phosphatase 1B 8528 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MMP-1/MMP-2 86 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 9 6779 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase-2 6627 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase-1 7046 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
B16 5829 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Bacillus subtilis 32866 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Pseudomonas fluorescens 1630 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Staphylococcus aureus 210822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Candida albicans 78123 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Tyrosinase 3884 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 255.27
Molecular Weight (Monoisotopic): 255.0895
AlogP: 2.75
#Rotatable Bonds: 3
Polar Surface Area: 69.56
Molecular Species: NEUTRAL
HBA: 3
HBD: 3
#RO5 Violations: 0
HBA (Lipinski): 4
HBD (Lipinski): 3
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.22
CX Basic pKa:
CX LogP: 2.96
CX LogD: 2.96
Aromatic Rings: 2
Heavy Atoms: 19
QED Weighted: 0.58
Np Likeness Score: -0.13
References
1.Nam NH, You YJ, Kim Y, Hong DH, Kim HM, Ahn BZ.. (2001) Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity., 11 (9):[PMID:11354370][10.1016/s0960-894x(01)00165-2]
2.Rajan P, Vedernikova I, Cos P, Berghe DV, Augustyns K, Haemers A.. (2001) Synthesis and evaluation of caffeic acid amides as antioxidants., 11 (2):[PMID:11206462][10.1016/s0960-894x(00)00630-2]
3.Jung M, Lee Y, Park M, Kim H, Kim H, Lim E, Tak J, Sim M, Lee D, Park N, Oh WK, Hur KY, Kang ES, Lee HC.. (2007) Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors., 17 (16):[PMID:17596944][10.1016/j.bmcl.2007.06.016]
4.Fu J, Cheng K, Zhang ZM, Fang RQ, Zhu HL.. (2010) Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials., 45 (6):[PMID:20181415][10.1016/j.ejmech.2010.01.066]
5.Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA.. (2013) Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors., 23 (5):[PMID:23375794][10.1016/j.bmcl.2013.01.027]
6.Misra K, Maity HS, Nag A, Sonawane A.. (2016) Radical scavenging and antibacterial activity of caffemides against gram positive, gram negative and clinical drug resistance bacteria., 26 (24):[PMID:27865704][10.1016/j.bmcl.2016.10.089]
7.Jo H, Choi M, Sim J, Viji M, Li S, Lee YH, Kim Y, Seo SY, Zhou Y, Lee K, Kim WJ, Hong JT, Lee H, Jung JK.. (2017) Synthesis and biological evaluation of caffeic acid derivatives as potent inhibitors of α-MSH-stimulated melanogenesis., 27 (15):[PMID:28619537][10.1016/j.bmcl.2017.06.011]
8.Ullah S, Kang D, Lee S, Ikram M, Park C, Park Y, Yoon S, Chun P, Moon HR.. (2019) Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells., 161 [PMID:30347330][10.1016/j.ejmech.2018.10.025]